Parlodel treatment of patients with pathospermia.
The response to bromoergocryptine (Parlodel, Sandoz) was examined in 42 pathospermic patients. The authors conclude that Parlodel did not influence the spermiogram considerably. Serum prolactin levels were lowered significantly, while the FSH, LH, testosterone, 17-alpha-hydroxyprogesterone and 17-beta-oestradiol concentrations did not change. Improvement was reported in potentia coeundi in one third of the patients.
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009845:Oligospermia / Q000097:blood / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood; D013081:Sperm Motility / Q000187:drug effects; D013739:Testosterone / Q000097:blood
D006908:Hydroxyprogesterones; D001971:Bromocriptine; D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone